Cloning, expression and molecular analysis of recombinant Netrin-A protein of Lucilia sericata Meigen (Diptera: Calliphoridae) larvae

• Published in: SAGE open medicine Vol. 12; p. 20503121231223607
• Main Authors: Moemenbellah-Fard, Mohammad Djafar, Bagheri, Masoumeh, Bonyani, Mehdi, Sedaghat, Hamed, Raz, Abbasali, Azizi, Kourosh, Soltani, Abouzar, Alipour, Hamzeh
• Format: Journal Article
• Language: English
• Published: England SAGE Publications 01-01-2024
• Subjects: Original; blowfly; gene; nucleotide; recombinant protein; Sf9; Arthropod; BEVS
• ISSN: 2050-3121; 2050-3121
• DOI: 10.1177/20503121231223607

(Diptera: Calliphoridae) is used in larval therapy for wound healing. Netrin-A is an enzyme secreted from the salivary glands of these larvae, and has a central role in neural regeneration and angiogenesis. This study aimed to produce the recombinant Netrin-A protein from
larvae by the baculovirus expression vector system in the Sf9 insect cell line.
The coding sequence of Netrin-A was cloned, amplified in the pTG19 vector, and then cloned in the pFastBac HTA vector. It was then transformed into DH10Bac, and the recombinant Bacmid was subsequently transfected into Sf9 cells. The recombinant Netrin-A was purified by Ni-NTA agarose. The evaluation was done using SDS-PAGE and western blot, respectively. Finally, its concentration was calculated with the Bradford assay.
The molecular weight of this protein was 52 kDa with 404 amino acids. The signal peptide was located between amino acids 24 and 25. The concentration of Netrin-A was calculated to be 48.8 μg/ml. It reaffirmed the characterized gene codes of
Netrin-A in a previous study.
The generation of recombinant Netrin-A could be used in larval therapy, and as a biomarker in certain diseases. The netrin-A of
was unprecedentedly cloned and expressed in a eukaryotic cell line. Given that this larva is FDA-approved, and non-pathogenic, it conduces to research on the development of maggot therapy in future.